Covid-19 action. Expansion of vial production to create industrial base capabilities for national defense

Ended Cooperative Agreement Awarded Last action

Award ID
W58P052220005
Recipient
Awarding agency
Obligated
$33,211,016

Award facts

Assistance listing
12.360 Research on Chemical and Biological Defense
Completion date
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Place of performance
Newtown, PA 18940, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Covid-19 action $0
Amendment Covid-19 action: the purpose of this modification is to DE-obligate funds for DOD agreement closeout. -$14,031,190
Amendment Covid-19 action: purpose of this modification was an administrative change for mocas and gfebs. $0
Amendment Covid-19 action: the purpose of this modification is to transition the agreement to the HHS successor agreement via memorialization effective 31 may 2023 and… $0
Amendment Covid-19 action: the purpose of this modification is to DE-OB funding to support HHS continuation agreement, updated security requirements and administrative… -$47,242,206
Original award $94,484,412

Quick answers

Who received award W58P052220005?

W58P052220005 was awarded to Ompi Of America Inc. by Defense Contract Management Agency (Department of Defense) on February 25, 2022.

How much is award W58P052220005 worth?

$33,211,016 has been obligated on W58P052220005.

Which agency awarded W58P052220005?

Defense Contract Management Agency (Department of Defense) awarded W58P052220005, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login